Autopsy report · NCT03136900

Impact on the Nitrogen Balance, Autonomy, Safety and Tolerance of Enteral Diets Made of With Nutrilon Without Lactose® Fortified by Concentration Versus by Maltodextrin and Oil Supplementation,After Surgery for Congenital Heart Disease, in Infants.

“Recuitment to slow”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 11 months before it stopped.
• 41 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Queen Fabiola Children's University Hospital

Sponsor type

University, hospital or other

Conditions

Congenital Heart Disease in Children

Interventions

Nutrilon without lactose® fortified by concentration; Nutrilon without lactose® fortified by Maltodextrin and oil supplementation

Participants

41

Sites

1

Countries

Belgium

Trials that died the same way

• Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
  “Due to slow accrual” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.